Local and forreign funds are selling now. They would keep on selling thus price expect to drop further down even have minor technical rebound just temporary only, after that would be down again. It's down trend until the WHO announcement about pandemic under control later. When WHO make the announcement would deeply drop to its bottom and then price consolidate at its bottom part for a long period at which is the best time for bottom fishing that I might aim for.

Thor85, how do u I quit job? I am the boss I order my people to do the job.

Thor85, I am smart don't have glove stocks.

Watch the following to know the further price drop of glove counters coming :

https://youtu.be/_axFGnW-7FE

Don't go in now can be trapped. If u really want to buy for long-term, wait for WHO to announce the pandemic under control during which would have another deep drop again that might lead to its bottom. Then, its price would be consolidated at its bottom part for a long long time that is the best time for bottom fishing.

It might break $4 going lower again in this week.

It seems many have disappeared from this forum, they might have cut loss already no more here.

Most likely can say goodbye to $5, might never see $5 until next new pandemic come.

Only two ways for those trapped, either u cut loss release from this counter move your money to other counters u think can earn to cover back your loss or the other way is just to buy more at its bottom part for average down and then forget it keep it for long-term don't know many years to wait for next new pandemic come lead to another bull.

The main mistake u all have made was too believe and optimistic about the PE, high target price and the estimates or projection made by ibs or someones like kyy that induced u all continue to hold tight tight and missed the golden chances of release for profit taking. Now is too late to regret.

Stock market not purely rely on figures, calculations or estimates, it also depends on most people concensus that form the market trend, market sentiment and market trading movement. We as investors need to use some trading strategy, trading skills and trading tools like chart analysis to beat the market and not only focus too much on the company fundamentals.

The lowest in history of supermx is $1 to $2 pre-bonus issue and pre-pandemic not the $4.33.

It's not yet bottom as long as WHO not yet announce the pandemic under control. It still has deep drop again during the announcement from WHO later.

The deep drop today not really caused by RSS but is heavy selling from local and forreign funds for profit taking since their holding cost is very low, some funds might have bought it pre-pendemic plus bonus issue made their holding cost very low.

gnath_77, I had bought and holding 300 lots Genting at its bottom part averaged cost $3.20 now making paper profit as its current market price around $4.68, 200 lots CIMB bought at its bottom averaged cost $3.10 now making paper profit as its current price around $4.30.

gnath_77, I agree with u. Only u buy the stock with good fundamentals at low price near to its bottom level that is called buy undervalued stocks but if u buy at high price during its peak even the company with good fundamentals is not buy undervalued but it's buy overvalued stock.

Don't talk so much how serious the virus be and how worst the pandemic be, it doesn't help to rescue supermx because most people now have mind set of glove counters now in down trend would deeply dropping for the sight of pandemic going to be under control. People and funds selling off to release or reduce holding of glove stocks. Its nonstop price drop due to their heavy selling force.

Where are those always talking high demand for gloves, high ASP, ongoing super profit, high PE and high target price $24,$12, $11.80 ets? Lai Lai come to rescue it from nonstop dropping.

Supermx earning super profit now drops below Genting which currently making loss. Where is Ibelieve? He said very bad on Genting that will sell its casino. Why Genting price now higher than supermx?

Today supermx price now $4.57 already dropped below Genting now $4.68.

When WHO announce the pandemic under control later it's possible drop to around $3.

Where is thor85? Last night he said will up trend today. Why not now?

Watch the following to know the further price drop of glove counters coming :

https://youtu.be/_axFGnW-7FE

thor85, u day and night also in dreaming. Are u going to push the price yourself tomorrow?

Watch the following to know the further price drop of glove counters coming :

https://youtu.be/_axFGnW-7FE

Whether the stock holders can benefit or not from the additional capital money raised from dual listing depends on how the company make use of its additional capital for value added in its long-term financial performance. Glove companies financial performance highly rely on the demand and supply of gloves. Thus in short term dual listing can make more capital money for the company but no benefits to its stock holders who might be not good due to lower EPS and lower market price, in long term have to see the change of glove demand and supply that directly affect company financial performance whether the additional capital raised from dual listing can add value or not.

Even dual listing, there are different trading movement, different trend and sentiments in different stock markets. Thus the local klse market would be different from the listed forreign market in terms of market trend, market sentiments and market trading movement.

Yes company is benefit from the bigger market and the investors in the dual listed forreign market are to benefit but not the investors in local market here they won't get any much benefit since the EPS and market price being lower unless u invest to buy and hold its shares in listed forreign market.

Thus the dual listing might lead to market response of stock price drop in short term.

With the dual listing in other countries, company would get additional capital money but the number of shares issued would increase to dilute EPS that lead to lower target price and also lower market price given unchanged PE ratio. This is benefit to company for getting more money but not good to retailers who expect for capital gain from the increase of market price.

Watch the following for your stock portfolio :

https://youtu.be/FKi87Lt_2Z0

All talk shiok shiok sendiri for self condolences here. It seems very desperate many of u.

The coming event to see now is the supermx with super profit has its market price going below Genting market price soon because supermx with super profit standing at price $4.84 in down trend whereas Genting standing at price $4.61 in up trend. Wait to see it might happen in the near term.

What u all say here just for shiok shiok sendiri for self condolences of being trapped losing money. Never mind what u all say here let time to present it, not u say to happen. We wait to see who is struggling in stock portfolio.

Signn, it seems u are very desperate not me because u are trapped in supermx losing money.

China Develops New Drug That Cures Coronavirus Faster Without Vaccine

https://worldtopnewsng.com/?p=30261

A NEW drug is being tested by scientists at China’s Peking University
A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.
The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China’s prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.
Sunney Xie, director of the university’s Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

“When we injected neutralising antibodies into infected mice, after five days, the viral load was reduced by a factor of 2,500,” said Xie.
“That means this potential drug has (a) therapeutic effect.”
The drug uses neutralising antibodies – produced by the human immune system to prevent the virus infecting cells – which Xie’s team isolated from the blood of 60 recovered patients.
A study on the team’s research, published Sunday in the scientific journal, Cell, suggests that using the antibodies provides a potential “cure” for the disease and shortens recovery time.
Xie said his team had been working “day and night” searching for the antibody.

“Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled.”
He said he hopes that the drug will be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

“Planning for the clinical trial is underway,” said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.
“The hope is these neutralising antibodies can become a specialised drug that would stop the pandemic,” he said.
China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.
But, the World Health Organisation has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma – a blood fluid – from recovered individuals who have developed antibodies to the virus enabling the body’s defences to attack it.
More than 700 patients have received plasma therapy in China, a process which authorities said showed “very good therapeutic effects”.
“However, it (plasma) is limited in supply,” Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).
Xie said his researchers had “an early start” since the outbreak started in China before spreading to other countries.
Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 – clinical trials in the US showed it shortened the recovery time in some patients by a third – but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.
The study showed that, if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to “extend to a few months”.
More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

“We would be able to stop the pandemic with an effective drug, even without a vaccine,” he said.

Learner King, Yes supermx will be back one day may be when next new pandemic come but don't know when may be many many years later, definitely not now nonstop dropping.

If U think stock dual listing even listing in USA will push up the price that shows u are very innocent may be is the newbies lack of understanding and experience of stock market.

Don't always think that pandemic will be forever, nothing will be forever and nothing will be at the peak forever. Just think logically now is the peak time for glove companies with its super profit and high demand for gloves and we still in the pandemic but all the glove stocks including supermx price nonstop dropping, what would happen on its price if on one day later pandemic really under control or over of course it might take some time of one or two years.

Since all glove stocks just finished its super bull down from its peak that heavy selling pressure from a lot of retailers trapped waiting to release and less or no big players, no hot money do speculation to push up price, it's difficult to go up much again in this one or two years prior to the end of pandemic. Furthermore market already changed to other play themes no more focus on glove counters as long as most investors and funds forsee economy recovery to take place soon with the rollout of vaccines even u all don't like to see. It's the fact happening now out of your control u need to face and take it even u don't like. Think it logically.

Topglove and hartalega are supported by its boss, its major stock holders. EPF and other funds, and it's retailers because these two already in klse index composite long time ago that they formed a substantial part of EPF and Funds holding.

Whereas supermx is mainly held by retailers much rely on retailers support and its major stock holders but currently it seems less or even no support from funds especially EPF because it was just included in klse and its market cap falling now due to price drop that might cause it to be kicked out again from klse index composite in the next review.

Thus even with price dropping topglove price would be more stable and higher compared to supermx which its price would be more volatile and lower. Thus u can see supermx price at first higher than topglove but now becomes lower than topglove.

Supermx current price is $4.84 in down trend whereas Genting current price is $4.61 in up trend. As supermx price might go lower and Genting price might go higher that on one day later supermx with super profit might have its market price below Genting which is currently making loss due to pandemic.

Apprentice, Genting has 28 billions to 30 billions cash in company much more than supermx only with 4 billions cash, genting has also about 30 billions retained earnings indicated by its balance sheet that more than sufficient to support its recent loss of only 1 billion in the worst year of 2020 furthermore it starts getting profit in 4th quarter of 2020 expect to recover its profit much more in 2021 with the launch of its sky world outdoor theme park soon. Its full recovery expected to be in next year 2022 and 2023.

Thus even with loss in the worst year of 2020, it still able to pay 15 cents dividend per share whereas supermx with super profit only pay 3.8 cents dividend per share.

Genting is much cash rich company with its great amount of retained accumulated previous earnings and its ongoing recovery in coming years I have no worries about it. Thanks for your care.

It seems u challenge the news and the scientist work, try to deny the scientist effort of discovering drugs for curing covid virus. The discovery of drugs for curing virus can lead to the drop of demand for gloves is my view. U don't agree never mind. Everybody can have different views. We disagree then let time to present it.

It seems Kltower1 very scared to see the news about virus can be effectively prevented or cured later and the pandemic under control later. Every time when this kind of news out he would deny its possibility to happen. Very negative character of offence u have. It's news just see and read only lah why want to challenge it.

It seems many of u like the virus and pandemic so much until don't want to let it go. I think u want to make friends with covid virus.

If China scientist really can develop drugs to cure covid virus without vaccines, why not USA and Europe scientists can do that later. Let us all wait to see let time to present it.

Let time to present it wait to see let the scientists do their work.

With drugs discovered to cure covid virus no need vaccines later that would definitely lead to the deep drop of demand for gloves. Then, what would happen on all the glove companies and glove counters?

China Develops New Drug That Cures Coronavirus Faster Without Vaccine

https://worldtopnewsng.com/?p=30261

A NEW drug is being tested by scientists at China’s Peking University
A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.
The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China’s prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.
Sunney Xie, director of the university’s Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

“When we injected neutralising antibodies into infected mice, after five days, the viral load was reduced by a factor of 2,500,” said Xie.
“That means this potential drug has (a) therapeutic effect.”
The drug uses neutralising antibodies – produced by the human immune system to prevent the virus infecting cells – which Xie’s team isolated from the blood of 60 recovered patients.
A study on the team’s research, published Sunday in the scientific journal, Cell, suggests that using the antibodies provides a potential “cure” for the disease and shortens recovery time.
Xie said his team had been working “day and night” searching for the antibody.

“Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled.”
He said he hopes that the drug will be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

“Planning for the clinical trial is underway,” said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.
“The hope is these neutralising antibodies can become a specialised drug that would stop the pandemic,” he said.
China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.
But, the World Health Organisation has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma – a blood fluid – from recovered individuals who have developed antibodies to the virus enabling the body’s defences to attack it.
More than 700 patients have received plasma therapy in China, a process which authorities said showed “very good therapeutic effects”.
“However, it (plasma) is limited in supply,” Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).
Xie said his researchers had “an early start” since the outbreak started in China before spreading to other countries.
Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 – clinical trials in the US showed it shortened the recovery time in some patients by a third – but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.
The study showed that, if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to “extend to a few months”.
More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

“We would be able to stop the pandemic with an effective drug, even without a vaccine,” he said.
Related

When price nonstop dropping a lot of self assumptions and dreaming by retailers about this and that for self condolences.

Yes, vaccines need time to show its effectiveness but supermx and other glove counters already showed its effects in advance by the selling pressure and nonstop price drop.